載入...
A Review of Currently Available Fenofibrate and Fenofibric Acid Formulations
Fenofibrate is a third-generation fibric acid derivative indicated as a monotherapy to reduce elevated low-density lipoprotein cholesterol, total cholesterol, triglycerides, and apolipoprotein B; to increase high-density lipoprotein cholesterol in patients with primary hyperlipidemia or mixed dyslip...
Na minha lista:
| 發表在: | Cardiol Res |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elmer Press
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5358213/ https://ncbi.nlm.nih.gov/pubmed/28352420 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4021/cr270w |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|